BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16055116)

  • 1. c-Myb inhibits myogenic differentiation through repression of MyoD.
    Kaspar P; Pajer P; Sedlak D; Tamaoki T; Dvorak M
    Exp Cell Res; 2005 Oct; 309(2):419-28. PubMed ID: 16055116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt binds prohibitin 2 and relieves its repression of MyoD and muscle differentiation.
    Sun L; Liu L; Yang XJ; Wu Z
    J Cell Sci; 2004 Jun; 117(Pt 14):3021-9. PubMed ID: 15173318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Ski activates MyoD in the nucleus of myoblastic cells through suppression of histone deacetylases.
    Kobayashi N; Goto K; Horiguchi K; Nagata M; Kawata M; Miyazawa K; Saitoh M; Miyazono K
    Genes Cells; 2007 Mar; 12(3):375-85. PubMed ID: 17352741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. v-Src inhibits myogenic differentiation by interfering with the regulatory network of muscle-specific transcriptional activators at multiple levels.
    Falcone G; Ciuffini L; Gauzzi MC; Provenzano C; Strano S; Gallo R; Castellani L; Alemà S
    Oncogene; 2003 Nov; 22(51):8302-15. PubMed ID: 14614454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transduction of MyoD protein into myoblasts induces myogenic differentiation without addition of protein transduction domain.
    Noda T; Fujino T; Mie M; Kobatake E
    Biochem Biophys Res Commun; 2009 May; 382(2):473-7. PubMed ID: 19289111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of phosphatidylserine externalization in the down-regulation of c-myb expression in differentiating C2C12 cells.
    Kaspar P; Dvorák M
    Differentiation; 2008 Mar; 76(3):245-52. PubMed ID: 17924964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization.
    Langen RC; Van Der Velden JL; Schols AM; Kelders MC; Wouters EF; Janssen-Heininger YM
    FASEB J; 2004 Feb; 18(2):227-37. PubMed ID: 14769817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galactosylceramide expression factor-1 induces myogenesis in MDCK and C3H10T1/2 cells.
    Ogura K; Niino YS; Tai T
    Arch Biochem Biophys; 2004 Jun; 426(2):279-85. PubMed ID: 15158678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylated myoblasts specifically deficient in MyoD autoactivation as a consequence of instability of MyoD.
    Horwitz M
    Exp Cell Res; 1996 Jul; 226(1):170-82. PubMed ID: 8660953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA-1 and c-myb crosstalk during red blood cell differentiation through GATA-1 binding sites in the c-myb promoter.
    Bartůnek P; Králová J; Blendinger G; Dvorák M; Zenke M
    Oncogene; 2003 Apr; 22(13):1927-35. PubMed ID: 12673198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and subcellular localization of myogenic regulatory factors during the differentiation of skeletal muscle C2C12 myoblasts.
    Ferri P; Barbieri E; Burattini S; Guescini M; D'Emilio A; Biagiotti L; Del Grande P; De Luca A; Stocchi V; Falcieri E
    J Cell Biochem; 2009 Dec; 108(6):1302-17. PubMed ID: 19830700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MyoD induces myogenic differentiation through cooperation of its NH2- and COOH-terminal regions.
    Ishibashi J; Perry RL; Asakura A; Rudnicki MA
    J Cell Biol; 2005 Nov; 171(3):471-82. PubMed ID: 16275751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the beta myosin heavy chain promoter by MEF-2D, MyoD, p300, and the calcineurin/NFATc1 pathway.
    Meissner JD; Umeda PK; Chang KC; Gros G; Scheibe RJ
    J Cell Physiol; 2007 Apr; 211(1):138-48. PubMed ID: 17111365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FHL3 binds MyoD and negatively regulates myotube formation.
    Cottle DL; McGrath MJ; Cowling BS; Coghill ID; Brown S; Mitchell CA
    J Cell Sci; 2007 Apr; 120(Pt 8):1423-35. PubMed ID: 17389685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The homeobox gene Arx is a novel positive regulator of embryonic myogenesis.
    Biressi S; Messina G; Collombat P; Tagliafico E; Monteverde S; Benedetti L; Cusella De Angelis MG; Mansouri A; Ferrari S; Tajbakhsh S; Broccoli V; Cossu G
    Cell Death Differ; 2008 Jan; 15(1):94-104. PubMed ID: 17932502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sox9 represses alpha-sarcoglycan gene expression in early myogenic differentiation.
    Hernández-Hernández JM; Delgado-Olguín P; Aguillón-Huerta V; Furlan-Magaril M; Recillas-Targa F; Coral-Vázquez RM
    J Mol Biol; 2009 Nov; 394(1):1-14. PubMed ID: 19729026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming ability.
    Pattabiraman DR; Sun J; Dowhan DH; Ishii S; Gonda TJ
    Mol Cancer Res; 2009 Sep; 7(9):1477-86. PubMed ID: 19737967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRB3 modulates C2C12 differentiation by interfering with Akt activation.
    Kato S; Du K
    Biochem Biophys Res Commun; 2007 Feb; 353(4):933-8. PubMed ID: 17207467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells.
    Chen J; Kremer CS; Bender TP
    Oncogene; 2006 May; 25(19):2758-72. PubMed ID: 16407849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FLASH acts as a co-activator of the transcription factor c-Myb and localizes to active RNA polymerase II foci.
    Alm-Kristiansen AH; Saether T; Matre V; Gilfillan S; Dahle O; Gabrielsen OS
    Oncogene; 2008 Aug; 27(34):4644-56. PubMed ID: 18408764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.